Tag: Rhythm’s obesity drug shows 19.8% placebo-adjusted BMI reduction in Phase 3
April 03, 2025
Health
Breakthroughs in Metabolic Health, Muscle Regeneration, and Real-World Data Integration
Introduction Innovation in clinical research is rapidly reshaping therapeutic strategies across obesity, muscle-wasting diseases, and trial design optimization. New data…